Myotilin overexpression enhances myopathology in the LGMD1A mouse model

Sean M. Garvey, Yutao Liu, Sara E. Miller, Michael A. Hauser

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Missense mutations in the myotilin gene cause limb-girdle muscular dystrophy type 1A (LGMD1A). We set out to examine the effect of overexpression of wild-type myotilin in an LGMD1A mouse model by crossing wild-type and mutant transgenic mice. Compared to single-transgenic mutant mice, double-transgenic mice overexpressing myotilin showed more severe muscle degeneration, enhanced myofibrillar aggregation, and earlier onset of aggregation. These data suggest that strategies aimed at lowering total myotilin levels in LGMD1A patients may be an effective therapeutic approach.

Original languageEnglish (US)
Pages (from-to)663-667
Number of pages5
JournalMuscle and Nerve
Volume37
Issue number5
DOIs
StatePublished - May 1 2008
Externally publishedYes

Fingerprint

Transgenic Mice
Missense Mutation
Muscles
Genes
Muscular dystrophy, limb-girdle, type 1A
Therapeutics

Keywords

  • Central nuclei
  • LGMD1A
  • Muscular dystrophy
  • Myofibrillar myopathy
  • Myotilin

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Myotilin overexpression enhances myopathology in the LGMD1A mouse model. / Garvey, Sean M.; Liu, Yutao; Miller, Sara E.; Hauser, Michael A.

In: Muscle and Nerve, Vol. 37, No. 5, 01.05.2008, p. 663-667.

Research output: Contribution to journalArticle

Garvey, Sean M. ; Liu, Yutao ; Miller, Sara E. ; Hauser, Michael A. / Myotilin overexpression enhances myopathology in the LGMD1A mouse model. In: Muscle and Nerve. 2008 ; Vol. 37, No. 5. pp. 663-667.
@article{3b65b5d6b8094fac968ab873edac3650,
title = "Myotilin overexpression enhances myopathology in the LGMD1A mouse model",
abstract = "Missense mutations in the myotilin gene cause limb-girdle muscular dystrophy type 1A (LGMD1A). We set out to examine the effect of overexpression of wild-type myotilin in an LGMD1A mouse model by crossing wild-type and mutant transgenic mice. Compared to single-transgenic mutant mice, double-transgenic mice overexpressing myotilin showed more severe muscle degeneration, enhanced myofibrillar aggregation, and earlier onset of aggregation. These data suggest that strategies aimed at lowering total myotilin levels in LGMD1A patients may be an effective therapeutic approach.",
keywords = "Central nuclei, LGMD1A, Muscular dystrophy, Myofibrillar myopathy, Myotilin",
author = "Garvey, {Sean M.} and Yutao Liu and Miller, {Sara E.} and Hauser, {Michael A.}",
year = "2008",
month = "5",
day = "1",
doi = "10.1002/mus.20994",
language = "English (US)",
volume = "37",
pages = "663--667",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Myotilin overexpression enhances myopathology in the LGMD1A mouse model

AU - Garvey, Sean M.

AU - Liu, Yutao

AU - Miller, Sara E.

AU - Hauser, Michael A.

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Missense mutations in the myotilin gene cause limb-girdle muscular dystrophy type 1A (LGMD1A). We set out to examine the effect of overexpression of wild-type myotilin in an LGMD1A mouse model by crossing wild-type and mutant transgenic mice. Compared to single-transgenic mutant mice, double-transgenic mice overexpressing myotilin showed more severe muscle degeneration, enhanced myofibrillar aggregation, and earlier onset of aggregation. These data suggest that strategies aimed at lowering total myotilin levels in LGMD1A patients may be an effective therapeutic approach.

AB - Missense mutations in the myotilin gene cause limb-girdle muscular dystrophy type 1A (LGMD1A). We set out to examine the effect of overexpression of wild-type myotilin in an LGMD1A mouse model by crossing wild-type and mutant transgenic mice. Compared to single-transgenic mutant mice, double-transgenic mice overexpressing myotilin showed more severe muscle degeneration, enhanced myofibrillar aggregation, and earlier onset of aggregation. These data suggest that strategies aimed at lowering total myotilin levels in LGMD1A patients may be an effective therapeutic approach.

KW - Central nuclei

KW - LGMD1A

KW - Muscular dystrophy

KW - Myofibrillar myopathy

KW - Myotilin

UR - http://www.scopus.com/inward/record.url?scp=42549141686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42549141686&partnerID=8YFLogxK

U2 - 10.1002/mus.20994

DO - 10.1002/mus.20994

M3 - Article

VL - 37

SP - 663

EP - 667

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 5

ER -